Skip to content
Screener
Q3 '26Q2 '26Q1 '26Q2 '25
-$87.66M—-$67.26M-18.5%-$61.71M-39.3%-$56.74M—
$3.7M—$3.2M-3.0%$3.27M-4.1%$3.3M—
$8.06M—$8.24M+50.1%$6.4M+34.8%$5.49M—
-$54.86M—-$57.94M-18.9%-$80.39M-51.2%-$48.75M—
$2.16M—$933K+506%$3.78M+403%$154K—
————-$259.93M-444%——
$3.49M———$378.89M+1,743%——
$4.99M———$38.57M-10.1%-$66.08M—
-$57.01M—-$58.88M-20.4%-$84.17M-56.1%-$48.91M—

FAQ

Where does Generate Biomedicines, Inc.'s cash flow data come from?
Every line is extracted from Generate Biomedicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.